Total Funding
92
94
Total FundingVenture - Series Unknown raised
Growth Score
9 pts
Heat Score
35 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
878
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.
- Deborah D. Ascheim: Chief Medical OfficerPast Role: StrideBio, Chief Medical Officer
Fari Izadyar: Senior ScientistPast Role: PrimeGen Biotech, Director of Research/ Senior Scientist
About the Company
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases. Founded on research from the Wyss Institute at Harvard Medical School, Rejuvenate Bio has developed innovative therapies aimed at addressing chronic age-related diseases in both humans and animals. The company has established a gene
therapy pipeline with significant potential in treating chronic diseases. They leverage clinically validated gene targets and an effective delivery method to ensure long-lasting and well-tolerated gene expression.
